Bindu Kalesan Selected Research

Bindu Kalesan Research Topics

Disease

16	Thrombosis (Thrombus) 06/2015 - 05/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014 - 12/2011
5	Stroke (Strokes) 10/2016 - 02/2012
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2013 - 06/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2011
4	Hemorrhage 10/2014 - 12/2012
3	Myocardial Infarction 10/2016 - 08/2011
3	Acute Coronary Syndrome 06/2015 - 02/2012
3	Death (Near-Death Experience) 01/2014 - 08/2011
2	Endocarditis 11/2021 - 01/2020
2	Wounds and Injuries (Trauma) 10/2020 - 04/2019
2	Ischemic Stroke 01/2019 - 03/2013
2	Breast Neoplasms (Breast Cancer) 10/2015 - 07/2015
2	Cardiogenic Shock 07/2015 - 09/2014
2	Atrial Fibrillation 10/2014 - 01/2013
2	Anemia 01/2014 - 04/2012
2	Transient Ischemic Attack 03/2013 - 02/2012
1	Asymptomatic Diseases 02/2021
1	Vascular System Injuries 10/2020
1	Pulmonary Embolism 01/2019
1	Aortic Rupture 01/2018
1	Disease Progression 01/2018
1	Diabetes Mellitus 01/2017
1	Hypertension (High Blood Pressure) 10/2016
1	Unstable Angina 10/2016
1	Heart Failure 10/2016
1	Flushing 07/2015
1	Hot Flashes 07/2015
1	Heart Diseases (Heart Disease) 06/2015
1	Renal Insufficiency (Renal Failure) 10/2014
1	Shock 09/2014
1	Aneurysm (Aneurysms) 03/2014
1	Patent Foramen Ovale 03/2013
1	Embolism (Embolus) 03/2013
1	Pathologic Constriction (Stenosis) 09/2012
1	Coronary Disease (Coronary Heart Disease) 09/2012
1	Ischemia 09/2012
1	Hypersensitivity (Allergy) 06/2012
1	Malnutrition (Nutritional Deficiencies) 05/2012
1	Frailty 05/2012
1	Cognitive Dysfunction 05/2012
1	ST Elevation Myocardial Infarction 04/2012
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2012
1	Arthritis (Polyarthritis) 03/2009
1	Neoplasms (Cancer) 03/2008

Drug/Important Bio-Agent (IBA)

4	Sirolimus (Rapamycin)FDA Link 08/2013 - 12/2011
3	Pharmaceutical PreparationsIBA 11/2021 - 07/2015
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 04/2012
2	PolymersIBA 08/2013 - 12/2011
2	MetalsIBA 06/2012 - 04/2012
2	Everolimus FDA Link 03/2012 - 02/2012
2	BESIBA 12/2011 - 08/2011
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	HDL CholesterolIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 10/2016
1	human ERBB2 proteinIBA 10/2015
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 07/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2015
1	Tamoxifen FDA LinkGeneric 07/2015
1	omega-Chloroacetophenone (Mace)IBA 06/2015
1	CreatinineIBA 01/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2013
1	Vitamin K FDA Link 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2012

Therapy/Procedure

17	Stents 06/2015 - 05/2011
8	Drug-Eluting Stents 05/2014 - 06/2011
6	Percutaneous Coronary Intervention 06/2015 - 04/2012
5	Therapeutics 07/2015 - 08/2011
5	Transcatheter Aortic Valve Replacement 01/2013 - 06/2011
3	Secondary Prevention 03/2013 - 01/2012
2	Length of Stay 02/2021 - 10/2014
2	Patient Readmission 01/2019 - 10/2014
2	Activities of Daily Living (ADL) 05/2012 - 03/2008
1	Carotid Endarterectomy 02/2021
1	Surgical Amputation (Amputations) 10/2020
1	Vascular Surgical Procedures 04/2019
1	Endovascular Aneurysm Repair 01/2018
1	Extracorporeal Membrane Oxygenation 07/2015
1	Heart Transplantation (Grafting, Heart) 09/2014
1	Heart-Assist Devices 09/2014
1	Arthrodesis 03/2009